Press Releases

LAVAL, Quebec, Feb. 4, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in three investor conferences.Paul S. Herendeen, executive vice president and chief financial officer, Sam Eldessouky, senior vice president and corporate controlle

NEW YORK, Feb. 4, 2020 /PRNewswire/ -- pCare™ announced today that it has been named the category leader for Interactive Patient Systems (IPS) for the fifth consec

CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief Financial Officer, will present a corporate overview at the 22nd Annual

CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2020 BIO CEO & Investor Conference on

BOSTON, Feb. 4, 2020 /PRNewswire/ -- Samus Therapeutics, Inc. ("Samus" or the "Company"), a privately held, Boston-based, biopharmaceutical company developing epichaperome inhibitors  to intervene in pathological processes and initiate the degradation of disease-associated proteins, today announced

REHOVOT, Israel, Feb. 4, 2020 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the launch of its updated corporate website. The new website has a clean uncluttered design, improved functionality and enhanced rich content focused on the Company's growth into its core business segments: Medical Aes

HOLON, Israel, Feb. 4, 2020 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the United States Patent and Trademark Office (USPTO) has granted the Company a new patent for methods of scree

SAN DIEGO, Feb. 4, 2020 /PRNewswire/ -- Plex Pharmaceuticals, Inc. ("Plex"), today announced it has been awarded a $600,000 Phase I Small Business Innovation Research grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to develop novel antiviral drug candidate(s) for t

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, today announced the start of a pivotal study to determine the efficacy of using MRI/US fusion imaging technology to direct focal ablation of prostate tissue using nanoparticle-directed laser ablation. T

COLLIERVILLE, Tenn., Feb. 4, 2020 /PRNewswire/ -- AMDT Holdings, Inc. develops disruptive products to address existing and emerging needs in the extremity market. The clinical use of the SixFix™ Circular Fixation System began in January, 2020. Initial surgeries were conducted in Tennessee and Ohio